# Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity

> **NCT00440102** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 655 (actual)

## Conditions studied

- Intubation; Difficult

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Etomidate

## Key facts

- **NCT ID:** NCT00440102
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 655 (ACTUAL)
- **Last updated:** 2011-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00440102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00440102, "Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00440102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*